MR-107A-01
- Generic Name
- MR-107A-01
Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
Phase 2
Completed
- Conditions
- Pain, AcutePostoperative PainPain
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-10-01
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- Mylan Inc.
- Target Recruit Count
- 114
- Registration Number
- NCT04571515
- Locations
- 🇺🇸
Research Facility 101, Salt Lake City, Utah, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath